SCHEMBL8710366

SCHEMBL8710366

CCCCOC(=O)Nc1c(F)cc(Cl)cc1F

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 9/20 0.52
SMN1; SMN2 Q16637 8/20 0.52
NPC1 O15118 7/20 0.52
HPGD P15428 6/20 0.52
CYP1A2 P05177 4/20 0.52
CYP2C19 P33261 4/20 0.52
CYP2C9 P11712 2/20 0.52
L3MBTL1 Q9Y468 4/20 0.51
ALDH1A1 P00352 4/20 0.51
LMNA P02545 2/20 0.51
TSHR P16473 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
EPHX2 P34913 1/20 0.46
KDM4E B2RXH2 2/20 0.46
CASP1 P29466 1/20 0.46
MAPT P10636 1/20 0.46
MAPK1 P28482 1/20 0.46
MCL1 Q07820 1/20 0.46
NFKB1 P19838 1/20 0.43
STAT1 P42224 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16696407 0.85 RAB9A (0.47) RAB9ASMN1; SMN2NPC1HPGDCYP1A2
SCHEMBL7558526 0.84 NLRP3 (0.54) RAB9ASMN1; SMN2NPC1CYP1A2CYP2C19
SCHEMBL29666364 0.76 RAB9A (0.70) RAB9ASMN1; SMN2NPC1HPGDCYP1A2
SCHEMBL7554735 0.75 NLRP3 (0.45) RAB9ASMN1; SMN2NPC1CYP1A2CYP2C19
SCHEMBL16374744 0.75 RAB9A (0.68) RAB9ASMN1; SMN2NPC1HPGDCYP1A2
SCHEMBL30729910 0.74 SMN1; SMN2 (0.54) RAB9ASMN1; SMN2NPC1HPGDCYP1A2
SCHEMBL30445349 0.74 SMN1; SMN2 (0.42) RAB9ASMN1; SMN2NPC1HPGDCYP1A2
SCHEMBL4593845 0.74 L3MBTL1 (0.55) RAB9ASMN1; SMN2NPC1HPGDCYP1A2
SCHEMBL21059157 0.74 RAB9A (0.73) RAB9ASMN1; SMN2NPC1HPGDCYP1A2
SCHEMBL4852614 0.74 NLRP3 (0.63) RAB9ASMN1; SMN2NPC1HPGDCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0880508-A1 QUINAZOLINE DERIVATIVES AS VEGF INHIBITORS ZENECA LIMITED (GB) 1998-12-02 EP disclosed
WO-1997030035-A1 QUINAZOLINE DERIVATIVES AS VEGF INHIBITORS ZENECA LIMITED (GB) 1997-08-21 WO disclosed